The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital.

Jones, M; Micallef, C; Tyler, N; Wong, V K; Enoch, D A

Jones, M; Micallef, C; Tyler, N; Wong, V K; Enoch, D A.

Afiliação

Jones M; Pharmacy Department, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Micallef C; Pharmacy Department, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Clinical Microbiology & Public Health Laboratory, National Infection Service, Public Health England, Addenbrookes Hospital, Cambridge, UK.
Tyler N; Pharmacy Department, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Wong VK; Clinical Microbiology & Public Health Laboratory, National Infection Service, Public Health England, Addenbrookes Hospital, Cambridge, UK.
Enoch DA; Clinical Microbiology & Public Health Laboratory, National Infection Service, Public Health England, Addenbrookes Hospital, Cambridge, UK. Electronic address: david.enoch@addenbrookes.nhs.uk.

J Infect ; 83(3): e9-e11, 2021 09.

Article em En | MEDLINE | ID: mdl-34329673

Assuntos

Antifúngicos; Monitoramento de Medicamentos; Antifúngicos/uso terapêutico; Humanos; Centros de Atenção Terciária; Reino Unido; Voriconazol/uso terapêutico

Palavras-chave

Audit; Therapeutic drug monitoring; Voriconazole

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Antifúngicos Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Infect Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google